High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2025Q4
FY2026Q1
547.40M
+4.5%
--
--
552.60M
+1.82%
--
--
569.24M
+5.3%
--
--
Estimates Revision
The market is revising Upward the revenue expectations for American Healthcare REIT, Inc. (AHR) for FY2025, with the revenue forecasts being adjusted by 0.59% over the past three months. During the same period, the stock price has changed by 18.89%.
Revenue Estimates for FY2025
Revise Upward
+0.59%
In Past 3 Month
Stock Price
Go Up
+18.89%
In Past 3 Month
10 Analyst Rating
0Wall Street analysts forecast AHR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for AHR is 40.30 USD with a low forecast of 37.00 USD and a high forecast of 45.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
9 Buy
1 Hold
0 Sell
Strong Buy
0Current: 40.650
Low
37.00
Averages
40.30
High
45.00
0Current: 40.650
Low
37.00
Averages
40.30
High
45.00
Citizens JMP
Outperform
maintain
$40 -> $45
2025-08-11
New
Reason
Citizens JMP
Price Target
$40 -> $45
2025-08-11
New
maintain
Outperform
Reason
Citizens JMP raised the firm's price target on American Healthcare REIT to $45 from $40 and keeps an Outperform rating on the shares. The company reported a "beat and raise" Q2, the analyst tells investors in a research note. The firm believes the investment story "has legs for multiple years to come" and continues to recommend the stock.
Baird
Wesley Golladay
Outperform
initiated
$41
2025-07-18
Reason
Baird
Wesley Golladay
Price Target
$41
2025-07-18
initiated
Outperform
Reason
Baird analyst Wesley Golladay last night initiated coverage of American Healthcare REIT with an Outperform rating and $41 price target. The firm views the company as one of the better investments to gain exposure to the expected multi-year growth of senior managed housing. Baird sees strong organic growth from the company's senior housing and senior health campus segments amid a favorable supply and demand backdrop.
Baird
Wesley Golladay
Outperform
initiated
$41
2025-07-17
Reason
Baird
Wesley Golladay
Price Target
$41
2025-07-17
initiated
Outperform
Reason
Baird analyst Wesley Golladay initiated coverage of American Healthcare REIT with an Outperform rating and $41 price target.
Scotiabank
Nicholas Yulico
initiated
$42
2025-06-30
Reason
Scotiabank
Nicholas Yulico
Price Target
$42
2025-06-30
initiated
Reason
Scotiabank analyst Nicholas Yulico initiated coverage of American Healthcare REIT with an Outperform rating and $42 price target.
Scotiabank
Outperform
initiated
$42
2025-06-30
Reason
Scotiabank
Price Target
$42
2025-06-30
initiated
Outperform
Reason
As previously reported, Scotiabank initiated coverage of American Healthcare REIT with an Outperform rating and $42 price target. The firm like American Healthcare's high exposure to the Seniors Housing segment given its "bullish" view on the segment's growth outlook for 2025-2027, the analyst tells investors. The firm also cites the REIT's strong operating platform and secondary market exposure.
KeyBanc
Austin Wurschmidt
Overweight
maintain
$34 -> $40
2025-06-11
Reason
KeyBanc
Austin Wurschmidt
Price Target
$34 -> $40
2025-06-11
maintain
Overweight
Reason
KeyBanc analyst Austin Wurschmidt raised the firm's price target on American Healthcare REIT to $40 from $34 and keeps an Overweight rating on the shares. Following recent meetings with management and Q1 earnings, the firm views American Healthcare REIT as remaining in an attractive position to capitalize on strong long-term care fundamentals. With the summer selling season in senior housing largely underway, and management striking an upbeat tone around the core fundamentals of the business, American Healthcare REIT's operators appear poised to drive value by utilizing various levers to drive NOI, KeyBanc adds. The company should also benefit from its improving cost of capital and a growing pipeline of opportunities, which should lead to accretive, external growth investments in its RIDEA portfolio.
See All Ratings
Valuation Metrics
The current forward P/E ratio for American Healthcare REIT Inc (AHR.N) is 63.58, compared to its 5-year average forward P/E of 567.83. For a more detailed relative valuation and DCF analysis to assess American Healthcare REIT Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
567.83
Current PE
63.58
Overvalued PE
1743.55
Undervalued PE
-607.88
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Strongly Overvalued
5Y Average EV/EBITDA
16.40
Current EV/EBITDA
21.86
Overvalued EV/EBITDA
18.89
Undervalued EV/EBITDA
13.92
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Strongly Overvalued
5Y Average PS
1.69
Current PS
3.04
Overvalued PS
2.35
Undervalued PS
1.02
Financials
Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AHR News & Events
Events Timeline
(ET)
2025-08-07
16:42:39
American Healthcare REIT reports Q2 FFO 42c, consensus 40c
2025-05-08 (ET)
2025-05-08
16:46:59
American Healthcare REIT reports Q1 normalized FFO 38c , consensus 37c
2025-02-27 (ET)
2025-02-27
16:24:11
American Healthcare REIT reports Q4 normalized FFO 40c, consensus 40c
Sign Up For More Events
Sign Up For More Events
News
Preview
4.0
08-12BenzingaExpert Outlook: American Healthcare REIT Through The Eyes Of 6 Analysts
Preview
9.5
08-09NewsfilterAmerican Healthcare REIT, Inc. (AHR) Q2 2025 Earnings Call Transcript
Preview
7.0
08-09SeekingAlphaAmerican Healthcare REIT raises 2025 NFFO guidance to $1.64–$1.68 amid strong NOI growth and pipeline expansion
Sign Up For More News
People Also Watch
FAQ
What is American Healthcare REIT Inc (AHR) stock price today?
What is American Healthcare REIT Inc (AHR)'s business?
What is the price predicton of AHR Stock?
What is American Healthcare REIT Inc (AHR)'s revenue for the last quarter?
What is American Healthcare REIT Inc (AHR)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for American Healthcare REIT Inc (AHR)'s fundamentals?
How many employees does American Healthcare REIT Inc (AHR). have?